Not Signed In - Drip Infusion 100 Receives Approval As Additional Indication Of Treating Behcet's Disease With Refractory Uveoretinitis
Sun, 28 Jan 2007 08:00 AM EST
... Tanabe Seiyaku Co., Ltd. has received approval for anti tumor necrosis factor (TNF)-a monoclonal antibody preparation REMICADE(R) for Drip Infusion 100 (generic name: infliximab) for extended indication of treating "Behcet's disease complicated with refractory uveoretinitis which does not respond to conventional therapies", for the first time in the world. [click link for full article] ...
Related Topics
- Nesiritide
- Acetaminophen and Propoxyphene
- Gum Disease
- Ondansetron Hydrochloride Injection (Home Infusion)
- Refractory Pain
- Diseases & Conditions
- Vaccine Testing & Approval
- Anemia
- Behcet's Syndrome
- Heart Disease
- Bone Disease
- Zoledronic Acid for Injection
- Lung Diseases & Disorders
- Huntington's Disease
- Kidney Disease
- Rare Diseases
- Crohn's Disease
- Graves' Disease
- Autoimmune Diseases
- Periodontal Disease
email this page
print this page
bookmark this page
feedback on this page
